Park Medi World IPO: An Analysis

Key Points

• Strong investor demand: 8.10x subscription rate indicates significant interest.
• Institutional investors drove most of the demand – 15.15x for NIIs.
• Retail investors showed moderate interest – 3.16x subscription rate.
• Funds will be used for debt repayment, hospital expansion, equipment, and acquisitions.
• Promoters hold a large stake (95.55%) with a significant post-IPO reduction.
• Strong financial performance reported, boosting confidence in the company.

The Park Medi World IPO, which opened for bidding on December 10, 2025, and closed on December 12, 2025, saw a massive response from investors. The initial offering included up to Rs 770 crore in fresh shares and Rs 150 crore offered for sale by Dr. Ajit Gupta.

Investors submitted bids for a staggering 33,88,30,572 shares, considerably more than the 4,18,18,182 shares the company initially offered. This resulted in an 8.10 times subscription rate, demonstrating high demand for the company’s shares.

The different categories of investors showed distinct preferences. Non-Institutional Investors (NIIs) were the biggest drivers, subscribing 15.15 times, followed by Qualified Institutional Buyers (QIBs) at 11.48 times. Retail Individual Investors subscribed at a more modest 3.16 times.

The funds raised from the IPO will be strategically allocated. A significant portion (Rs 380 crore) will go towards repaying existing debt. Rs 60.5 crore is earmarked for building a new hospital under the Park Medicity (NCR) banner. Another Rs 27.45 crore will be used for buying medical equipment, and the remaining funds will be used for inorganic acquisitions and general corporate purposes.

Dr. Ajit Gupta and Dr. Ankit Gupta, along with the promoter group, currently hold a substantial 95.55% of the company’s shares. However, after the IPO, their stake is projected to decrease to approximately 82.89%. Park Medi World is a prominent private hospital chain in North India, boasting 3,250 beds across 14 NABH-accredited hospitals.

The company operates across 30+ specialties and has grown through strategic acquisitions. They are planning to expand further, with new hospitals planned in Ambala, Panchkula, Rohtak, Gorakhpur, and Kanpur, aiming for a total bed capacity of 4,900 by FY28. Their revenue is primarily driven by internal medicine (29.65%) and government schemes (83.38%).

Bed occupancy is currently at 68.14%, with a healthy outpatient volume of 3,92,049 patients. Ahead of the IPO, Park Medi World successfully raised Rs 275.99 crore from 23 anchor investors on December 9, 2025, by allotting 1.70 crore shares at Rs 162 each.

The company reported strong financial results, with a consolidated net profit of Rs 139.14 crore and an income from operations of Rs 808.66 crore for the nine months ended on June 30, 2025.

This IPO signals strong confidence in Park Medi World’s growth potential and its position in the Indian healthcare market.